While pharmacy group Dis-Chem is growing revenue, profits are under pressure as it fights for market share in a tough economy. Group revenue rose 9.4% to R17.9 billion in the six months to end August, ...
Dan and Mark Saltzman, the heirs of Dis-Chem founder Ivan Saltzman, have sold shares worth more than R640m, seven months after their parents gave them shares worth nearly R7bn. In a regulatory filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results